Z Hussein
Overview
Explore the profile of Z Hussein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussein Z, Alzamily A
Georgian Med News
. 2024 Jul;
(349):154-160.
PMID: 38963220
Mitochondrial dysfunction in autism leads to impair the mitochondria's ability to synthesis adenosine triphosphate (ATP) by impairment citric acid cycle as well as increase anaerobic glycolysis. Aim - measuring and...
2.
Bhargava R, Hussein Z, Dorward N, Grieve J, Jaunmuktane Z, Marcus H, et al.
Acta Neurochir (Wien)
. 2022 May;
164(8):2095-2103.
PMID: 35532784
Purpose: IgG4-related hypophysitis (IgG4-RH) is a rare chronic inflammatory condition of the pituitary gland. This study reports the presentation, management and outcomes for patients with histologically proven IgG4-related hypophysitis. Methods:...
3.
Mafauzy M, Khoo E, Hussein Z, Yusoff Azmi N, Siah G, Mustapha F, et al.
Med J Malaysia
. 2020 Jul;
75(4):419-427.
PMID: 32724007
Introduction: Prediabetes, typically defined as blood glucose levels above normal but below diabetes thresholds, denotes a risk state that confers a high chance of developing diabetes. Asians, particularly the Southeast...
4.
Hussein Z, Aziz N, Dhanaraj E, Brahmachari B, Kothekar M
Med J Malaysia
. 2020 Jul;
75(4):372-378.
PMID: 32723997
Introduction: Biosimilar insulins have the potential to increase access to treatment among patients with diabetes mellitus (DM), reduce treatment costs, and expand market competition. There are no published studies evaluating...
5.
6.
Loganadan N, Huri H, Vethakkan S, Hussein Z
Pharmacogenomics J
. 2016 Jan;
16(3):209-19.
PMID: 26810132
The clinical response to sulphonylurea, an oral antidiabetic agent often used in combination with metformin to control blood glucose in type 2 diabetes (T2DM) patients, has been widely associated with...
7.
8.
van Hasselt J, Gupta A, Hussein Z, Beijnen J, Schellens J, Huitema A
CPT Pharmacometrics Syst Pharmacol
. 2015 Aug;
4(7):386-95.
PMID: 26312162
Frameworks that associate cancer dynamic disease progression models with parametric survival models for clinical outcome have recently been proposed to support decision making in early clinical development. Here we developed...
9.
van Hasselt J, Gupta A, Hussein Z, Beijnen J, Schellens J, Huitema A
CPT Pharmacometrics Syst Pharmacol
. 2015 Aug;
4(7):374-85.
PMID: 26312161
Quantitative model-based analyses are helpful to support decision-making in drug development. In oncology, disease progression/clinical outcome (DPCO) models have been used for early predictions of clinical outcome, but most of...
10.
Tong C, Hussein Z, Noor N, Mohamad M, Ng W
QJM
. 2014 Aug;
108(1):49-50.
PMID: 25099611
No abstract available.